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Exercise-associated hyponatremia (EAH) was initially described in the 1980s in endur-
ance athletes, and work done since then has conclusively identified that overdrinking 
beyond thirst and non-osmotic arginine vasopressin release are the most common 
etiologic factors. In recent years, EAH has been described in a broader variety of athletic 
events and also has been linked to the development of rhabdomyolysis. The potential 
role of volume and sodium depletion in a subset of athletes has also been described. 
This review focuses on the most recent literature in the field of EAH and summarizes 
key new findings in the epidemiology, pathophysiology, treatment, and prevention of this 
condition.
Keywords: exercise, hyponatremia, rhabdomyolysis, water, pathogenesis
iNTRODUCTiON
Exercise-associated hyponatremia (EAH) refers to a low blood sodium concentration ([Na+]) that 
develops during or immediately following physical activity (sport or recreation). For most labs, the 
diagnostic threshold for hyponatremia is any blood [Na+] below135 mmol/L regardless of the pres-
ence or absence of signs and symptoms.
Isolated cases of severe, clinically significant, EAH with associated encephalopathy were first 
reported in the 1980s in ultramarathon (>42 km) runners (1, 2). Ironman triathletes—particularly 
those competing in hot climates—were also finishing races with mild EAH (3). Since then, EAH cases 
have been reported outside of prolonged endurance exercise and in (otherwise healthy) individuals 
participating in team sports (4, 5), shorter races (6), and yoga classes (7, 8). Unfortunately, despite 
increased recognition and research performed on EAH worldwide (9), athletes continue to die from 
complications associated with hyponatremic encephalopathy (10–14).
The purpose of this review is to provide an update on EAH. Sports medicine’s evolving understand-
ing of EAH appears to more closely align with the clinical spectrum and pathological manifestations 
of hyponatremia seen in outpatient and inpatient care settings. We aim to highlight new information 
with regards to the epidemiology, pathophysiology, treatment, and prevention of EAH and not a 
comprehensive overview, which is available elsewhere (9, 15–17).
ePiDeMiOLOGY OF eAH
Once a rare and isolated phenomenon limited to ultrarunners (1, 2), hikers (18, 19), and Ironman 
triathletes (3, 20, 21), EAH awareness blossomed in the early 2000s when hyponatremia began 
surfacing in marathon runners (22–26). The tragic deaths of two female charity marathon runners 
in 2003 (25) fully exposed this fatal complication of exercise to sports medicine personnel as well 
as the lay public. Scientific interest piqued in parallel with growing EAH incidence rates around the 
FiGURe 1 | Reported cases of exercise-associated hyponatremia 
(eAH) along the spectrum of pathophysiology. Cases of EAH per sport 
are superimposed upon the broad spectrum of volemic pathophysiology: (1) 
hypervolemia—overzealous drinking with arginine vasopressin (AVP) 
stimulated fluid retention and minimal sodium losses or sodium over-
correction (black triangle); (2) euvolemia—moderate drinking with AVP 
stimulated fluid retention and mild (compensable) sodium losses (gold 
triangle); and (3) hypovolemia—moderate drinking (volemic thirst) with AVP 
stimulated fluid retention, and under-replaced sodium losses (red triangle).
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world (27–37). Collective studies demonstrated that overzealous 
fluid consumption (above the dictates of thirst) coupled with 
fluid retention [exercise-induced non-osmotic arginine vasopres-
sin (AVP) secretion] was the primary cause of EAH in athletes 
participating in prolonged endurance exercise (9, 25).
It has been hypothesized that mentruant females are at 
increased risk for developing EAH compared with males (9, 26, 
38), due to estrogen-mediated impairment of cerebral adaptation 
to rapid osmotic swelling (39). However, males are not immune 
toward developing asymptomatic (5) or severe symptomatic 
EAH with fatal consequences (10–13, 32, 40–43). Although the 
majority of EAH cases are documented in females, a large study 
performed on Boston Marathon runners suggested that the 
apparent sex difference disappeared when data were adjusted for 
body mass index and racing times (29).
Over the past decade, EAH deaths have been confirmed in the 
lay press in high school football players following practice (10–12), 
a soldier on the first day of Ranger training (44), a policeman par-
ticipating in a 19 km bike ride (45), a college student performing 
calisthenics for a fraternity (42), a bushwalker (43), an ironman 
triathlete (14), and a canoeist during an ultradistance race (13). 
Additionally, a highly fit solider died during a 50  km training 
march with both hyponatremic encephalopathy and exertional 
heat stroke (41). The literature also reports symptomatic cases of 
EAH after long distance swimming (46), mountain cycling (47), 
yoga (7, 8), 2 h of weightlifting plus tennis (48), and in an indi-
vidual with cystic fibrosis after low-intensity lawn bowling (49).
Cases of asymptomatic EAH (diagnosed through routine 
screenings for research purposes) have recently been documented 
in 33% of 10 rugby players following an 80-min match (4), 70% 
of 30 elite junior rowers during an extended training period (5), 
11% of 1,089 Ironman triathletes tested post-race (50), 6% of 
33 endurance cyclists tested pre- and post-race (51), 67% of 15 
ultramarathon runners testing during the race (52), 5% of 161 
marathon and half-marathon runners tested pre-race, and 8% of 
192 marathon and half-marathon runners tested post-race (6). 
Thus despite increased awareness of the hazards of overdrinking, 
EAH fatalities, case reports, and incidence rates have spread into 
a wider variety of sporting activities.
Figure 1 summarizes recent reported cases of EAH, referenced 
above, within a wide variety of sporting and recreational activi-
ties. These cases are superimposed upon the broad spectrum of 
pathophysiological volume states associated with hyponatremia 
ranging from hypervolemia to hypovolemia. Of note, exercise-
induced non-osmotic AVP secretion (with persistent fluid 
retention) permeates throughout the entire pathophysiological 
spectrum. A comprehensive reference list of all EAH cases is 
provided in a recent review (9).
PATHOGeNeSiS OF eAH
Exercise-associated hyponatremia has a complex pathogen-
esis with multiple overlapping etiologies (15). In 2015, the Third 
International Exercise-Associated Hyponatremia Consensus 
Development Conference concluded that the primary etiol-
ogy and mechanism leading to EAH was the overconsumption 
of hypotonic fluids likely in combination with non-osmotic 
stimulation of AVP secretion (9). However, recent data support 
other mechanisms that may be operable with variable contribu-
tions to the overall development of hyponatremia. This section 
reviews both known as well as more novel mechanistic features 
(Figure 2).
Overconsumption of Hypotonic Fluids
The majority of athletes who develop hyponatremia demonstrate 
an increase in total body water (TBW) relative to that of total body 
exchangeable sodium (15, 29, 30). This develops from by the inges-
tion of hypotonic fluids (water or sports drinks) in excess of sweat, 
urine, and insensible (mainly respiratory and gastrointestinal) 
losses (i.e., drinking in excess). It is likely that conditioned behavior 
as well as inappropriate hydration recommendations (that are often 
taken to the extreme such as recommendations to “drink as much 
as possible”) account for this excessive fluid intake (9, 22). This is 
compounded by the wide availability of fluids along event courses.
The data supporting overhydration as the major mechanism 
involved in EAH is derived from the observations of weight gains 
seen in the majority of, but not all, athletes who become symp-
tomatic with EAH (30). These rapid weight gains can only occur 
through ingestion of fluids in excess of body losses. As an example 
of the magnitude of these fluid intakes, individuals with normal 
glomerular filtration rates who are ingesting a Western diet can 
excrete between 500 and 1,000 mL/h of water. When non-renal 
losses of water (such as sweat and insensible fluid losses) are 
included into the net fluid balance equation, individuals can 
excrete 1,000–1,500  mL/h of dilute urine before developing 
water retention (15). While some athletes may drink this much, 
many do not and thus additional factors must be involved in the 
development of EAH.
FiGURe 2 | Pathogenic factors involved in the development of exercise-associated hyponatremia (eAH). EAH develops from multiple mechanisms and 
can occur in both states of volume excess and depletion with AVP secretion occurring in both cases. It is important to note that none of these mechanisms occur in 
isolation, and they can overlap in any given patients (for example, sodium loss and excess water intake can occur in the same patient) Abbreviations: Na, sodium; 
AVP, arginine vasopressin; GI, gastrointestinal; CNS, central nervous system; RAAS, renin–angiotensin–aldosterone system.
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Non-Osmotic AvP Secretion
Arginine vasopressin is the major hormonal regulator of 
water excretion, and abnormalities in AVP secretion are 
likely operative in the majority of athletes with EAH (25, 
53–56). Under normal circumstances, AVP is suppressed 
in the presence of hypoosmolality. In some athletes, AVP is 
not appropriately suppressed (as typified by the finding of 
inappropriately elevated urine osmolality) (25, 52–56). This 
release of AVP leads to water retention in the distal tubule 
of the kidney and impaired water excretion. Coupled with 
excessive water intake, inappropriate water retention will lead 
to hyponatremia. Several potential stimuli to AVP release in 
exercising athletes include non-specific stresses (pain, emo-
tion, and physical exercise), nausea/vomiting, hypoglycemia, 
exposure to heat, and medication use (such as non-steroidal 
anti-inflammatory drugs and selective serotonin reuptake 
inhibitors) (57–61).
A more speculative mechanism is that AVP may be stimulated 
by the release of inflammatory cytokines (25). In particular, 
interleukin-6 (IL-6) has been shown to increase during exercise 
by both physiologic (as it is involved in the mobilization of energy 
stores during exercise) and pathologic means (with muscle 
inflammation from breakdown) and may serve as a stimulus for 
AVP production. A study on 15 participants in ultramarathons, 
found a significant positive correlation between AVP and IL-6 
(r = 0.31, P < 0.05) but not between AVP and blood glucose or 
ambient temperature (52).
While AVP is secreted in response to volume depletion, the 
typical levels of volume depletion in athletes are less than 7–10%; 
the threshold for AVP release. However, a study on rowers during 
a 4-week training camp revealed an inappropriate lack of AVP 
suppression occurring with EAH (plasma copeptin levels were 
used as a surrogate marker of AVP). In this case, the potential 
non-osmotic stimuli to AVP were thought to be related to hypo-
volemia as reflected by an association with increased hematocrits 
(5). Thus, the role of hypovolemia as stimulus for EAH may be 
underappreciated.
Sweat Sodium Loss
The issue as to the contribution of sweat sodium loss to the devel-
opment of EAH remains controversial. Sodium loss from sweat 
is highly variable between individuals, and compared with the 
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general population, endurance athletes have lower sweat sodium 
levels (62, 63). The loss of hypotonic sweat would be expected 
to raise the serum sodium. However, sweat loss could contribute 
to the development of hyponatremia in two manners: (1) if the 
degree of fluid loss was sufficient to produce significant volume 
depletion and provides a stimulus to AVP release, thereby impair-
ing excretion of water and/or (2) through ingestion of fluids that 
were more hypotonic than the fluid losses. This scenario may 
contribute to the finding of EAH developing in some athletes 
with net weight loss.
Sodium Mobilization from internal  
Non-Osmotically Active Stores
A large amount of the total body sodium may exist in bone, 
skin, and cartilage stores that are not osmotically active but 
potentially recruitable into an osmotically active form (64). This 
may be as large as one fourth of the total sodium in the body. 
These sodium stores are reversibly bound to substances such as 
glycosaminoglycans and may be “dynamic,” meaning that that 
sodium can enter and exit this pool (65). Sodium exiting this pool 
may buffer the serum sodium and lower the risk of hyponatremia. 
On the other hand, sodium entering this pool may exacerbate 
hyponatremia (66). It has been hypothesized that athletes who 
develop EAH either cannot activate the exchangeable pool of 
sodium in response to sodium losses or alternatively sodium may 
move into non-osmotically active forms (30). The mechanisms 
that control the exchange of sodium between these compart-
ments are unknown, and this mechanism remains speculative. 
However, these exchangeable sodium stores may be the explana-
tion why some athletes gain significant weight yet do not become 
hyponatremic.
Other Factors
In addition to the excessive intake of water, glycogen 
metabolism may be an important component in the cause of 
hyponatremia that occurs without weight gain because each 
kilogram of glycogen can contain upwards of 3 kg of associ-
ated metabolic water (15). As glycogen is metabolized, water 
is released and if not excreted could lead to depression of the 
serum sodium.
As renal water excretion is dependent upon the delivery of 
filtrate to the diluting segments of the distal nephron, the neu-
rohormonal activation of the sympathetic nervous system and 
renin–angiotensin–aldosterone system that occurs with endur-
ance exercise may be contributory and permissive (15). This is 
due to the fact that catecholamines and angiotensin II increase 
sodium and water reabsorption in the proximal tubule. This 
means that there will be decreased filtrate that is delivered to 
the distal diluting segments of the kidney, eventually leading to 
impairments of free water excretion.
Another contributing factor at the end of an event may be 
rapid absorption of fluids from the gastrointestinal tract. In ath-
letes who may have a large amount of fluid in the stomach (from 
recent ingestion) and have elevated AVP levels, rapid absorption 
of this fluid (as gastrointestinal blood flow post-event increases) 
along with impaired free water excretion may set up athletes to 
develop hyponatremia (15).
The role of sodium ingestion during events remains a mat-
ter of debate, and there are little data supporting the concept 
that inadequate sodium intake either prior or during an event 
contributes to the development of EAH. Hoffman et  al. found 
that hyponatremia, as well as exercise-associated muscle cramp-
ing, dehydration, and nausea or vomiting, was unrelated to total 
sodium intake in participants of a 161  km ultramarathon (67, 
68). This was confirmed in a case study which demonstrated that 
oral sodium supplementation does not necessarily prevent symp-
tomatic EAH associated with overhydration (69). On the other 
hand, another study demonstrated that longer term (10  days) 
reduction in dietary sodium intake can cause reductions in 
plasma sodium concentration before as well as during exercise 
when fluid losses and ingestion are large and may consequently 
have adverse effects on physiological and functioning during 
such exercise (70).
Hypovolemic eAH
There has been debate in the literature as to the prevalence and 
role of hypovolemia in the pathogenesis of EAH. Earlier data 
supported the fact that the vast majority of EAH cases were in 
athletes with net weight gain and hypervolemia. However, in the 
past few years, more data have supported that hypovolemia is 
more prevalent than previously thought. In a recent Czech study 
on ultra-endurance races, 85% of the hyponatremic athletes were 
volume depleted based on body weight changes (71). Weight loss 
in EAH cases supports volume depletion as a contributor to EAH 
perhaps through non-osmotic AVP secretion as described above 
coupled with sodium losses.
NeweR CONCePTS iN eAH: 
RHABDOMYOLYSiS
A bidirectional association between rhabdomyolysis and EAH 
has been suggested in various studies and case reports (Figure 3) 
(72–74). Based on data from seven different ultra-endurance 
races and disciplines, Chìbkovà et al. reported that hyponatremic 
athletes tended to develop exercise-induced rhabdomyolysis 
more frequently than normonatremic ones (75). Cairns and 
Hew-Butler observed that transient hyponatremia preceded 
significantly higher elevation in creatine kinase (CK) during a 
marathon footrace (76). Rhabdomyolysis may be both an etio-
logical factor in the development of EAH as well as sequelae of its 
development. Rhabdomyolysis link to the development of EAH 
may be through stimulating AVP secretion, possibly through 
increases of IL-6 and CK (25). On the other hand, EAH may cause 
rhabdomyolysis through changes in intracellular potassium and/
or calcium concentrations, which reduce cell membrane stability 
and cause muscle cell injury (72). Interestingly, it is the return to 
normonatremia (cell volume decrease following a hypoosmotic 
increase), which appears to initiate the pathological intracellular 
calcium handling and consequent skeletal muscle injury (76).
TReATMeNT OF eAH
Exercise-associated hyponatremia is largely an acute hypona-
tremia, clinically defined as having an onset within 48 h (77). It 
FiGURe 3 | Putative bidirectional relationship between exercise-associated hyponatremia (eAH) and rhabdomyolysis. EAH may lead to rhabdomyolysis 
through changes in the skeletal muscle membrane (osmotic shock) and activation of reactive oxygen species (ROS) along with increases in intracellular calcium (Ca) 
that activate intracellular proteases and lead to cellular breakdown. Rhabdomyolysis either through this mechanism or by other means leads to local and systemic 
inflammation and release of interleukin-6 (IL-6), which may increase arginine vasopressin (AVP) levels further lowering serum sodium. Non-steroidal anti-inflammatory 
drug use may also contribute to excess AVP release.
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is unclear whether or not multistage races or frequent training 
bouts (over days to weeks) induce cerebral adaptations (i.e., 
extrusion of organic osmolytes such as glutamate, taurine, and 
myo-inositol), which would characterize the less symptomatic 
chronic form of hyponatremia (78). The ability of cerebral neu-
rons to resist osmotic swelling, via adaptive processes undertaken 
by surrounding astrocytes over 1–2  days, significantly affects 
both symptoms and treatment (78). Without data to support the 
chronic variant of EAH, however, we will discuss the treatment 
of EAH as an acute variant. Accordingly, the treatment of EAH is 
guided by clinical signs and symptoms (Figure 4).
Collective evidence from case studies (25, 26, 79–82) and 
case-controlled trials (22, 83, 84) confirm that intravenous 
(IV) administration of a hypertonic saline solution is the most 
effective treatment for reversing encephalopathy associated with 
symptomatic EAH while increasing blood [Na+] (84). To date, 
there have been no complications associated with this life-saving 
treatment despite concerns of central pontine myelinolysis (85) or 
pain and/or scarring from administration into a peripheral vein 
(86). The recommended hypertonic bolus is 100 mL of 3% saline 
(or closest equivalent) administered every 10 min until resolution 
of encephalopathy signs and symptoms (9). When EAH encepha-
lopathy is severe, hypertonic saline may be given in larger doses 
and at more frequent intervals, with as much as 950 mL of 3% 
saline needed to successfully reverse EAH encephalopathy in one 
case (87) and 40 mL of 20% saline used in another (46).
New evidence suggests that oral hypertonic saline solutions 
may reverse symptomatology (88) and reverse blood [Na+] 
(83, 84), when tolerated. Although these studies are prelimi-
nary, oral hypertonic solutions appears to be a more expedient 
option to classical treatment with fluid restriction. Exercisers 
with documented (biochemical) hyponatremia but with mild to 
moderate symptoms have responded favorably to small boluses 
of hypertonic solutions as either concentrated chicken broth 
(four bouillon cubes in 125  ml/one-quarter cup of water) (88) 
or 100 mL of 3% saline flavored with Crystal Light™ (83, 84). 
Although hypothesized, the efficacy of urea (89), mannitol, and/
or AVP antagonists has yet to be tested as viable treatment options 
for EAH.
Isotonic (0.9%) saline has been successfully utilized in the 
treatment of EAH (1, 2, 80). However, the clinical and biochemi-
cal response is quite delayed when compared with hypertonic 
FiGURe 4 | Treatment of exercise-associated hyponatremia (eAH) 
according to signs and symptoms. Evidenced-base treatment options for 
EAH associated with mild (yellow), moderate (orange), or severe clinical signs 
and symptoms.
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saline administration (days versus hours) (22, 80). The primary 
clinical concern with IV isotonic saline administration is exacer-
bation of fluid retention coupled with urinary sodium excretion 
(90) in the likelihood that exercise-associated non-osmotic AVP 
secretion is present (91). The only rare (but notable) exception 
is when EAH is associated with signs and symptoms of volume 
depletion, as noted above (i.e., elevated blood urea nitrogen, 
weight loss, and scant urine with urine [Na+] <30  mmol/L, 
thirst). In these rare pathophysiological exceptions (i.e., after 
prolonged exercise in hot conditions in unacclimitized individu-
als or in individuals with chronically elevated sweat or urinary 
sodium content), plasma volume expansion with both sodium 
and water (isotonic saline) may be preferred over administration 
of concentrated sodium solutions (hypertonic saline) (9, 77, 92). 
Serial monitoring of blood [Na+] should be performed regardless 
of treatment. When in doubt, hypertonic saline is an effective 
treatment option regardless of volemic status. Hypotonic solu-
tions are absolutely contraindicated when a diagnosis of EAH 
is confirmed.
PReveNTiON OF eAH
Prevention of EAH is of critical importance and requires organ-
ized educational programs with information disseminated to 
coaches, athletes and event staff regarding healthy hydration 
practices, sodium supplementation, and recognition and treat-
ment of EAH. All of the deaths attributable to EAH would have 
likely been prevented if individuals had a better understanding 
of hydration needs as well as being able to rapidly recognize the 
signs and symptoms of EAH.
education Programs
There are many misconceptions regarding hydration needs dur-
ing exercise that foster the belief that athletes and individuals 
performing even moderate levels of exercise should “drink as 
much fluid as possible” (93). Unfortunately, there are also various 
contests and challenges that are prevalent on the Internet that 
urge participants to drink as much water as possible in short 
periods of time, often with fatal consequences (94). Hoffman 
et  al. assessed the quality of information currently available to 
the public on the Internet regarding hydration recommendations 
during exercise (95). Not surprisingly, the quality of information 
was poor even for those sites that would be considered “medical” 
or “scientific.” For example, only 7.3% of 110 web sites discussed 
that fluid intake should be based upon thirst, and the potential 
risk of hyponatremia from overhydration was noted by less than 
half the websites (95). Dissemination of more appropriate hydra-
tion guidelines is critical, and we recommend that education 
programs stress the following concepts that are evidence based:
 1. Excessive fluid replacement that goes beyond thirst has not 
been shown to decrease the development of fatigue, muscle 
cramping or exertional heat stroke (9).
 2. Modest levels of dehydration are tolerable and pose little risk 
in healthy individuals. Studies indicate that fluid deficits less 
than and up to a volume approximately equal to 3% of normal 
body mass (or ~5% TBW) can be well tolerated (96).
 3. Utilize strategies during exercise to prevent overhydration.
 a. Drink according to thirst. Because fluid losses through sweat 
and urine are highly dynamic and variable across individuals 
participating in a variety of outdoor activities, recommending 
fixed ranges of fluid intake is not appropriate. The most indi-
vidualized hydration strategy before, during, and immediately 
following exercise is to drink fluids when thirsty. Following 
thirst as a real-time guide appears safe and effective (9, 97).
 b. Reduce the availability of fluids along the routes of exercise. 
This strategy has been shown to reduce the incidence of 
hyponatremia during endurance events (98, 99). However, 
further studies are needed in order to determine the optimal 
number and spacing of fluid stations in various environment 
conditions.
 c. Use monitoring of weight changes during exercise. Body weight 
is a reasonable, even if not precise, surrogate measure of hydra-
tion state, and can be used to assess changes in hydration state 
(9). Even if body weight changes are imprecise during longer 
duration exercise it will be the expectation is that athletes 
should not gain weight during the event. Weight gain is an 
indication that fluid intake has been in excess of fluid losses, 
and water overload is present to some degree (9). Therefore, 
those individuals with weight gain should reduce their fluid 
intake. Whenever possible, access to scales and education on 
personal weight changes that occur with exercise should be 
available. It is important to note that in some particular envi-
ronments EAH has been reported with substantial weight loss, 
therefore weight loss cannot always be considered a reliable 
approach for excluding the diagnosis of EAH.
Finally, we strongly recommend “grass-roots” efforts to adopt 
educational strategies to improve knowledge of safe hydration 
practices. These efforts should target a broad audience but must 
focus on those individuals such as coaches, event support staff 
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and medical personnel that are most likely to have the greatest 
influence on the behavior of athletes. There is evidence that such 
strategies do work to lower the incidence of EAH when imple-
mented (99–102). Furthermore, education programs should 
include recognition of the signs and symptoms of EAH as well as 
the need for immediate medical attention.
The Role of Sodium Supplementation
While there is common consensus that the primary strategy 
to prevent EAH is to avoid drinking excessive fluids, the role 
of sodium supplements in decreasing the risk of EAH remains 
controversial (68). Previous work on the influence of sodium sup-
plementation on plasma sodium levels has shown variable results. 
Vrijens and Rehrer showed that fluid replacement with a sports 
drink containing 18 mmol/L of sodium as compared with water, 
led to an attenuated fall in plasma sodium during 3 h of cycling in 
the heat (103). Anastasiou et al. showed that even small amounts 
of sodium ingested during 3 h of racing in the heat were sufficient 
to attenuate the decrease in plasma sodium (104). Similar findings 
were observed by Twerenbold et al. during a 4 h running time trial 
in temperatures ranging from 5 to 19°C. Again, sodium ingestion 
resulted in a smaller decrease in the plasma sodium concentra-
tion from pre- to post-run measurements in female athletes (105). 
Conversely, Barr et  al. reported no differences in the plasma 
sodium concentration at the end of 6 h of ergometer use in the 
heat, when either a water or saline solution was ingested (106).
More recent data have led to continued controversies regard-
ing the value of sodium supplementation. A case report has been 
recently published in which a runner with a prior history of EAH 
consulted a sports nutritionist who advised him to consume 
considerable amounts of supplemental sodium, which did not 
prevent him from developing symptomatic EAH during a sub-
sequent long run (69). A study involving 156 participants of a 
161 km race found a weakly positive relationship between sodium 
supplementation and post-race serum sodium concentrations; 
the authors concluded that sodium supplementation had a mini-
mal contribution on the prevention of hyponatremia (68). In nine 
endurance-trained men, each following a low- or high-sodium 
diet for 9 days, Koenders et al. found that, despite decreased uri-
nary sodium losses, plasma sodium was lower in the patients on 
low-sodium diet before and throughout exercise. They concluded 
that the general population recommendations to lower salt intake 
may not be appropriate for endurance athletes, particularly those 
training in the heat that may be at risk for EAH (70).
Turner et  al. examined the novel hypothesis that sodium 
excreted in sweat during physical activity offsets a significant frac-
tion of excess dietary sodium intake, and hence may contribute 
part of the health benefits of exercise. Hence, replacing sodium 
lost in sweat during exercise may improve physical performance 
and slightly lower the risk of EAH, but may attenuate the long-
term health benefits of exercise (107).
In conclusion, as reported on the Statement of the 3rd 
International Exercise-Associated Hyponatremia Consensus 
Development Conference, while sodium ingestion during a 
race may attenuate the fall in blood sodium concentrations, 
it cannot prevent EAH in the setting of excessive fluid intake 
(94). It is the amount of fluid ingested rather than the amount 
of sodium ingested during exercise that drives the final blood 
sodium concentrations. Sodium-containing sports drinks, which 
are hypotonic, will not prevent EAH in athletes who overdrink 
during exercise.
SUMMARY
The incidence of EAH continues to spread into a wider variety 
of sporting activities and cause unnecessary deaths in other-
wise healthy individuals. Drinking beyond thirst continues to 
be the primary pathophysiological factor in the development of 
EAH, regardless of mode of physical activity. Administration 
of hypertonic saline continues to be lifesaving, with treatment 
largely guided by clinical signs and symptoms. For mild to 
moderate EAH (without altered mental status), fluid restric-
tion or oral hypertonic saline is recommended while for severe 
symptomatic EAH (with altered mental status), urgent admin-
istration of IV boluses of 100 mL 3% NaCl is required. Drinking 
according to the dictates of thirst, during and immediately 
following exercise will prevent the development of EAH when 
exercise is performed in temperate climates with duration of 
less than 17 h.
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